University of Rochester

Arthur Jay Moss

Ilan Goldenberg

Mark Frederick Bocko

Jean-Philippe Yves Couderc

Shey-Shing Sheu

Charles E Sparks

James P Corsetti

Wojciech Zareba

Gisela Beutner

William E Boden

Ido Goldenberg

Daniel H Ryan

There is provided a medical device comprising a low intensity electromagnetic field source to increase the respiratory control index values (RCI) of mitochondria. The medical device may be implantable, such as a cardiac rhythm management device, a stent, or a vascular graft. The device may also be worn externally, such as a treatment device having a matrix of magnetic coils that is worn on the head for the treatment of various neurological conditions.

Low intensity magnetic field devices for treatment of cardiac and neurological disorders

An internal medical device for implantation into a human or animal where the internal medical device has an electric field source that may be an active source of electromotive force such as a battery or capacitor, or may be an electric field generating material such as an electret, piezoelectric, or the like.

Implantable devices that generate low intensity electric fields for the treatment of atherosclerotic disease and prevention of ischemic vascular events and methods of manufacture

Described is a method of determining the relative risk of an outcome based on an analysis of multiple risk factors. A graphical method is used to take values corresponding to risk parameters and an event outcome to produce a smoothed surface map representing relative risk over an entire space defined by n risk factors. Applying a query data point to the surface map permits the determination of the estimated outcome probability for the query data point, based on its location on the surface map. The method then reports a relative risk or other probability measure associated with the query data point. Also described is a method of analysis in which subpopulations previously identified as high-risk can be further analyzed with respect to risk posed by additional factors.

Identifying risk of a medical event

A method for analyzing an ECG signal includes obtaining a measurement of an area based repolarization interval from at least one beat in the electrocardiogram signal and detecting an altered ventricular repolarization based on the obtained measured area based repolarization interval.

Method and system for analyzing an electrocardiographic signal

A method is provided to lower serum cholesterol, total triglycerides and/or apoprotein B in a human by administering an effective amount of one or more Type IA antiarrhythmic agents to said human.

Growing community of inventors

Rochester, NY, United States of America

Arthur Jay Moss